Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 4Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Parathyroid Neoplasms 2Ovarian Neoplasms 2Otorhinolaryngologic Neoplasms 2Osteosarcoma 2Mixed Tumor, Mesodermal 2Mesothelioma, Cystic 2Mesothelioma 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Chondrosarcoma 2Carcinoma, Small Cell 2Breast Neoplasms 2Adenosarcoma 2Tracheal Neoplasms 1Thymoma 1Solitary Pulmonary Nodule 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Pulmonary Sclerosing Hemangioma 1

Interventions

belinostat 1Thoracoscopy 1Robotic Surgical Procedures 1Mitozytrex 1Mitomycin 1Iodized Oil 1Ethiodized Oil 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mediastinal Neoplasms × belinostat × Thoracic × Clear all
NCT00589290 2015-09-30

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
41 enrolled 8 charts
Thoracic

Mediastinal Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡